bioRxiv · 10.64898/2026.02.12.703707
A single-cell atlas and aging clock define biological age and risk-associated stem cell states in human hematopoiesis
Abstract
Aging of hematopoietic stem and progenitor cells (HSPCs) impairs regenerative capacity and predisposes to hematological diseases. Here, we constructed a comprehensive single-cell transcriptomic atlas comprising 186,123 CD34+ HSPCs spanning early prenatal development (6 post-conception weeks) to late adulthood (74 years). We identified two conserved core molecular programs (MPs) of inflammaging and RNA splicing / protein homeostasis. Leveraging these programs, we developed a machine learning-based stem cell aging clock from 84 donors. Applying this clock to acute myeloid leukemia (AML), we define Transcriptional Age Deviation (TAD), a novel metric of biological age divergence. We found that a biologically "younger" state (low TAD), reflecting oncofetal reprogramming, is a powerful independent predictor of poor survival in two large AML cohorts. Low TAD was associated with high-risk genetics and therapy resistance, and critically, it re-stratified patient outcomes within each ELN 2022 risk category. Our work establishes a quantitative link between stem cell aging biology and AML prognosis, offering a robust tool to refine clinical risk assessment.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Chen, H., Dong, P., Xu, J., Wang, G.. 2026-02-13. A single-cell atlas and aging clock define biological age and risk-associated stem cell states in human hematopoiesis. https://doi.org/10.64898/2026.02.12.703707
Cite the original work for its findings. Save a collection to share your selection of sources.